Disease Drug Development Packaging Pharma Conference 
Agency IQ
AUGUST 2, 2024
We expect the FDA to mark the occasion, especially since drug pricing continues to be such a potent issue in the Presidential election. The law created the entire generic drug pathway, and we expect that the FDA (and Congress) will do something to mark the occasion.
Agency IQ
MAY 3, 2024
Title Type Comments Close Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards Draft Guidance April 30 Early Alzheimer’s Disease: Developing Drugs for Treatment Draft Guidance May 13 Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the (..)
Expert insights. Personalized for you.
40 
Let's personalize your content